Solvay Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Solvay Stock Forecast and Price Target
If the average 2024 price target of 29.50€ recently set by two prominent experts for Solvay is met, there would be a potential downside of approximately -5.45% from the last closing price in April, 2024. The high estimate is 150.00€, and the low is 20.00€. If you are looking to invest in the stock, it's important to research and compare different companies.
-5.45% Downside
Solvay Fair Value Forecast for 2023 - 2025 - 2030
Solvay's Price has decreased by 100.00% In the last four years, from 71.00€ to 0.00€. In the next year, analysts believe that Fair Value will reach 146.15€ – an increase of 100.00%. For the next seven years, experts predict that Solvay's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$148.53 | Buy/Sell | $174.55 | 14.45% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$127.00 | Buy/Sell | $130.51 | 9.84% |
| RELIANCE Stock Forecast | Reliance Industries | Outperform |
10
|
Rp2.90k | Buy/Sell | Rp2.77k | 11.02% |
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£113.52 | Buy/Sell | £165.99 | 42.55% |
| NOVN Stock Forecast | Novartis | Hold |
10
|
CHF89.12 | Buy/Sell | CHF105.00 | 20.68% |
Solvay Revenue Forecast for 2023 - 2025 - 2030
Solvay's Revenue has grown In the last two years, rising from 9.71€B to 16.07€B – a growth of 65.44%. In the following year, the 8 analysts surveyed believe that Solvay's Revenue will decrease by 24.25%, reaching 12.17€B. According to professionals, by 2030, Solvay's Revenue will have decreased by 68.56%, falling down to 5.05€B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF222.20 | Buy/Sell | CHF307.83 | 22.64% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$26.27 | Buy/Sell | $32.87 | 16.10% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$273.01 | Buy/Sell | $303.65 | 16.20% |
.jpg)
Solvay Dividend per Share Forecast for 2023 - 2025 - 2030
Solvay's Dividend per Share has seen impressive growth In the last two years, rising from 3.75€ to 4.05€ – a growth of 8.00%. In the next year, analysts believe that Dividend per Share will reach 4.23€ – an increase of 4.44%. In 2030, professionals predict that Solvay's Dividend per Share will decrease by 40.00%, reaching 2.43€.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HON Stock Forecast | Honeywell International Inc | Outperform |
12
|
$194.79 | Buy/Sell | $219.12 | 14.23% |
| SAN Stock Forecast | Sanofi | Outperform |
16
|
87.70€ | Buy/Sell | 102.80€ | 24.29% |
| BP. Stock Forecast | BP p.l.c. | Outperform |
9
|
£5.26 | Buy/Sell | £7.50 | 42.02% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$48.86 | Buy/Sell | $58.15 | 12.57% |
| GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$67.08 | Buy/Sell | $87.82 | 19.26% |
| GSK Stock Forecast | GSK | Outperform |
12
|
£16.36 | Buy/Sell | £17.30 | 19.19% |
Solvay EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Solvay's EBITDA has grown, moving from 1.76€B to 3.02€B – an increase of 71.24%. For the next year, 14 analysts project Solvay's EBITDA to drop by 9.02%, reaching 2.75€B. Looking ahead to seven years, experts forecast that EBITDA will grow by 11.59%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 4063 Stock Forecast | Shin-Etsu Chemical | Outperform |
4
|
¥6.48k | Buy/Sell | ¥5.13k | 12.62% |
| SHW Stock Forecast | Sherwin Williams | Outperform |
15
|
$303.73 | Buy/Sell | $317.38 | 11.77% |
| ECL Stock Forecast | Ecolab | Hold |
18
|
$220.78 | Buy/Sell | $205.36 | 4.63% |
Solvay EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Solvay's EBIT has seen an increase, rising from 861.00€M to 2.25€B. This represents a growth of 160.74%. According to 7 prominent analysts, Solvay's EBIT will fall by 12.74% in the next year, reaching 1.96€B. By 2030, professionals believe that Solvay's EBIT will decrease by 59.20%, reaching 916.00€M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OXY Stock Forecast | Occidental Petroleum | Hold |
5
|
$67.33 | Buy/Sell | $65.72 | 3.97% |
| 1211 Stock Forecast | Saudi Arabian Mining Company (... | Underperform |
6
|
﷼51.50 | Buy/Sell | ﷼32.82 | -33.01% |
| APD Stock Forecast | Air Products and Chemicals | Outperform |
16
|
$234.68 | Buy/Sell | $310.73 | 12.92% |
Solvay EPS Price Prediction Forecast for 2023 - 2025 - 2030
Solvay's EPS has decreased by 100.00% In the last four years, from 5.81€ to 0.00€. In the next year, analysts believe that EPS will reach 11.96€ – an increase of 100.00%. For the next seven years, experts predict that Solvay's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAS Stock Forecast | BASF | Outperform |
12
|
51.32€ | Buy/Sell | 49.50€ | 9.12% |
| DOW Stock Forecast | Dow | Hold |
2
|
$56.98 | Buy/Sell | $57.75 | 5.30% |
| CTVA Stock Forecast | Corteva | Outperform |
12
|
$54.77 | Buy/Sell | $61.72 | 16.85% |
.jpg)